Kate H. C. Gowers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kate H. C. Gowers has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Sam M. Janes
Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK
20 shared publications - Adam Pennycuick
UCL Respiratory, University College London, London, UK
16 shared publications - Robert Edward Hynds
Epithelial Cell Biology in ENT Research (EpiCENTR) Group, Developmental Biology and Cancer Department, Great Ormond Street UCL Institute of Child Health, University College London, London, UK
15 shared publications - Nicholas McGranahan
Cancer Research UK Lung Cancer Centre of Excellence University College London Cancer Institute London UK
14 shared publications - Peter J. Campbell
Wellcome Sanger Institute
14 shared publications - Vitor Hugo Teixeira
Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK
14 shared publications
Latest Publications
- Open Access
Recovery of human upper airway epithelium after smoking cessation is driven by a slow-cycling stem cell population and immune surveillance
SUMMARY: The upper airway epithelium in humans is maintained in homeostasis by a resident population of basal stem cells. In the presence of tobacco smoke these gain mutations that significantly increase their risk of transformation to lung squamous cell carcinoma. Previous studies show that a small proportion of stem cells avoid the mutational damage caused by carcinogens in tobacco and are more abundant in the lungs of former smokers than ongoing smokers, indicating unexplained tissue-level genomic recovery. This mirrors epidemiological risk, which falls rapidly after quitting smoking. Somatic evolutionary mechanistic hypotheses have been proposed to explain these observations. Here, we present a computational framework to model each of these hypotheses within the upper airway epithelial stem cell population over the entire patient lifetimes of a cohort with diverse smoking histories. Applying a mechanistic learning approach based on a set of biologically informed metrics to single cell-derived whole-genome sequencing data, we identified subtle differences between epithelia modelled under different combinations of hypotheses. A slow-cycling subpopulation of stem cells, combined with suppression of immune predation of highly mutated stem cells while smoking, best matched observed data, a result converged upon by multiple distinct machine learning methodologies. Our findings, drawing on an evolutionary model of mutagen exposure at a whole-lifetime scale that is not feasible to model in vivo, reveal the mechanisms behind reduction in lung squamous cell carcinoma risk on cessation of smoking and inform future therapeutic interventions to prevent lung cancer initiation.
Open AccessRecovery of human upper airway epithelium after smoking cessation is driven by a slow-cycling stem cell population and immune surveillance
SUMMARY: The upper airway epithelium in humans is maintained in homeostasis by a resident population of basal stem cells. In the presence of tobacco smoke these gain mutations that significantly increase their risk of transformation to lung squamous cell carcinoma. Previous studies show that a small proportion of stem cells avoid the mutational damage caused by carcinogens in tobacco and are more abundant in the lungs of former smokers than ongoing smokers, indicating unexplained tissue-level genomic recovery. This mirrors epidemiological risk, which falls rapidly after quitting smoking. Somatic evolutionary mechanistic hypotheses have been proposed to explain these observations. Here, we present a computational framework to model each of these hypotheses within the upper airway epithelial stem cell population over the entire patient lifetimes of a cohort with diverse smoking histories. Applying a mechanistic learning approach based on a set of biologically informed metrics to single cell-derived whole-genome sequencing data, we identified subtle differences between epithelia modelled under different combinations of hypotheses. A slow-cycling subpopulation of stem cells, combined with suppression of immune predation of highly mutated stem cells while smoking, best matched observed data, a result converged upon by multiple distinct machine learning methodologies. Our findings, drawing on an evolutionary model of mutagen exposure at a whole-lifetime scale that is not feasible to model in vivo, reveal the mechanisms behind reduction in lung squamous cell carcinoma risk on cessation of smoking and inform future therapeutic interventions to prevent lung cancer initiation.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S5 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Pathway analysis comparing the illumina and Affymetrix datasets as described in Supplementary Methods.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Pathway analysis comparing the illumina and Affymetrix datasets as described in Supplementary Methods.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S4 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Immune cell deconvolution from molecular data. Relative proportions of immune cell subtypes are predicted from gene expression data using the Danaher method, and from methylation data using methylCIBERSORT. Differences between progressive and regressive groups are reported here.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Immune cell deconvolution from molecular data. Relative proportions of immune cell subtypes are predicted from gene expression data using the Danaher method, and from methylation data using methylCIBERSORT. Differences between progressive and regressive groups are reported here.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S1 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Details of molecular investigations performed on each sample. Clinical and outcome data is also presented. In all cases with a previous history of lung cancer, this was of squamous histology.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Details of molecular investigations performed on each sample. Clinical and outcome data is also presented. In all cases with a previous history of lung cancer, this was of squamous histology.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Markers used to define cell types in quantitative multiplex immunohistochemistry experiments.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Markers used to define cell types in quantitative multiplex immunohistochemistry experiments.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S1 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Details of molecular investigations performed on each sample. Clinical and outcome data is also presented. In all cases with a previous history of lung cancer, this was of squamous histology.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Details of molecular investigations performed on each sample. Clinical and outcome data is also presented. In all cases with a previous history of lung cancer, this was of squamous histology.